Click to Donate to ALS Association Greater New York Chapter Button
ALS Research Banner - The ALS Association Greater New York Chapter
ALS Research Overview

Read The ALS Association's White Paper on the State of ALS Research.

TREAT ALS

Read about the new initiative to accelerate clinical trials through ALS Research.

Meet The ALS Association's Senior VP of Research and Development

Read interviews with Lucie Bruijn, PhD.
>> 2004 interview
>> 2006 interview

Register

Click here to be added to our list and receive updates.

Contact Us

Phone: (800) 672-8857
Email: als@als-ny.org

Latest News

Read The ALS Association's White Paper on the State of ALS Research.

Topics Banner 2

Amyotrophic comes from the Greek language: A- means "no", myo refers to "muscle", and trophic means "nourishment"; amyotrophic therefore means "no muscle nourishment," which describes the characteristic atrophy of the sufferer's disused muscle tissue. Lateral identifies the areas in a person's spinal cord where portions of the nerve cells that are affected are located. As this area degenerates it leads to scarring or hardening (sclerosis) in the region.

In ALS, the progressive weakness that develops is due to selective death of motor neurons, the nerve cells that carry messages telling the muscles to contract. Motor neurons are unique cells, the longest in the body. All neurons extend a connecting fiber, the axon, to the next neuron or end organ. Some motor neurons in the spinal cord must extend their axon up to a meter, to reach the toes, for example, yet the cell body maintaining this extraordinary fiber is only of ordinary size. Metabolic demands on the motor neurons must be correspondingly extraordinary.

Organization of Research Areas

Each ALS Research Area is linked to an overview, news links and illustrative images. New research areas may be added as they become relevant to ALS research.

 Main Research Area 

Clinical Trials
Disease Process of ALS
Sub Research Area of Disease Process
Axon Structure and Dynamics  
Cell Death and Apoptosis
Cognitive Changes with ALS [Frontotemporal Dementia]
Glutamate
Inflammation
Mitochondria
SOD1 and ALS (copper zinc superoxide dismutase 1)
Laboratory Models of ALS
Therapies for ALS
Sub Research Area of Therapies
Cell Targets
Gene Therapy
RNA Therapy
Stem Cells
Trophic Factors